HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stina Garvin Selected Research

Radiotherapy

8/2019Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery.
7/2018Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery.
10/2017WRAP53β, survivin and p16INK4a expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer.
8/2017Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity.
1/2015Nuclear expression of WRAP53β is associated with a positive response to radiotherapy and improved overall survival in patients with head and neck squamous cell carcinoma.
10/2013Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
12/2010Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stina Garvin Research Topics

Disease

12Neoplasms (Cancer)
08/2019 - 12/2003
8Breast Neoplasms (Breast Cancer)
08/2021 - 12/2003
5Squamous Cell Carcinoma of Head and Neck
10/2017 - 12/2010
4Neoplasm Metastasis (Metastasis)
07/2018 - 12/2003
1Laryngeal Neoplasms (Laryngeal Cancer)
10/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2010
1Carcinogenesis
05/2007
1Fibrosarcoma
10/2004
1Lymphatic Metastasis
10/2004

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
10/2017 - 12/2010
2Estrogen ReceptorsIBA
08/2019 - 12/2003
2Proteins (Proteins, Gene)FDA Link
10/2017 - 01/2015
2Gentian Violet (Violet, Crystal)FDA Link
10/2017 - 01/2015
2SurvivinIBA
10/2017 - 10/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2008 - 12/2003
2Estradiol (Delestrogen)FDA LinkGeneric
03/2008 - 05/2007
2Estrogens (Estrogen)FDA Link
03/2008 - 12/2003
2SteroidsIBA
05/2007 - 08/2006
2TamoxifenFDA LinkGeneric
05/2007 - 12/2003
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
08/2021
1Phenobarbital (Luminal)FDA Link
08/2019
1human ERBB2 proteinIBA
08/2019
1AntigensIBA
08/2019
1Progesterone Receptors (Progesterone Receptor)IBA
08/2019
1ErbB Receptors (EGF Receptor)IBA
10/2017
1Pharmaceutical PreparationsIBA
10/2017
1Cetuximab (Erbitux)FDA Link
10/2017
1DNA (Deoxyribonucleic Acid)IBA
07/2015
1Antisense RNA (Anti-Sense RNA)IBA
01/2015
1Small Interfering RNA (siRNA)IBA
10/2013
1Fibronectins (Fibronectin)IBA
12/2010
1Indicators and Reagents (Reagents)IBA
03/2008
1Tissue Inhibitor of Metalloproteinase-1IBA
05/2007
1EndostatinsIBA
05/2007
1Matrix Metalloproteinases (MMPs)IBA
05/2007
1Therapeutic UsesIBA
05/2007
1Tissue Inhibitor of Metalloproteinase-2IBA
05/2007
1PolyphenolsIBA
01/2006
1Estrogen Receptor alphaIBA
01/2006
1ResveratrolIBA
01/2006
1Becaplermin (PDGF-BB)FDA Link
10/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2004
1Messenger RNA (mRNA)IBA
12/2003

Therapy/Procedure

7Radiotherapy
08/2019 - 12/2010
2Segmental Mastectomy (Lumpectomy)
08/2019 - 07/2018
2Therapeutics
10/2013 - 12/2010
1Chemoradiotherapy
10/2017